StockNews.com started coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a research report sent to investors on Sunday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Price Performance Sorrento Therapeutics stock opened at $0.12 on Friday. The company has a debt-to-equity ratio of 0.14, a current […]
StockNews.com began coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a research note issued to investors on Saturday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Stock Up 42.1 % Shares of SRNE opened at $0.15 on Friday. The company has a debt-to-equity ratio of 0.14, a […]
StockNews.com began coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a research note issued to investors on Saturday. The firm issued a hold rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Stock Up 42.1 % Shares of NASDAQ SRNE opened at $0.15 on Friday. The business has a fifty day simple moving […]
Sorrento Therapeutics (NASDAQ:SRNE) Now Covered by StockNews.com theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
StockNews.com initiated coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a report issued on Wednesday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Price Performance NASDAQ:SRNE opened at $0.04 on Wednesday. The business has a fifty day simple moving average of $0.08 and a two-hundred day simple […]